Funding was led by led by Temasek co Accuron Technologies. Tianda Pharmaceuticals, Haitong International were other new investors
Family-owned CMA CGM offered S$1.30 a share in cash, 6% above NOL‘s last closing price.This has been accepted by Temasek, which owns nearly 67% of N
Plans to offload assets have helped buoy Neptune Orient Lines Ltd's (NOL) share price by about 40 percent so far this year. The co has a market capita
Temasek is consolidating its holdings in the US, reducing stake in Thermo Fisher, Gilead Sciences, while increasing stake in EMC by 22%
CMA CGM is in exclusive talks to buy nearly 67 percent of NOL from state investor Temasek Holdings
© Copyright DEALSTREETASIA 2014-2019 All rights reserved.
Forgot your password?
We will never share your information with third parties.
Already have an account? Sign in here
If you don’t already have an account click the button below to create your account.
Unlock your competitive advantage in
rapidly evolving cape. Our packages
come with exclusive access to archive
content, data, discount on summit tickets & more
Be a part of our growing community now.